InMed Pharmaceuticals Inc
NASDAQ:INM

Watchlist Manager
InMed Pharmaceuticals Inc Logo
InMed Pharmaceuticals Inc
NASDAQ:INM
Watchlist
Price: 1.23 USD -2.38% Market Closed
Market Cap: 3.4m USD

Wall Street
Price Targets

INM Price Targets Summary
InMed Pharmaceuticals Inc

There are no price targets for INM.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
InMed Pharmaceuticals Inc Competitors:
Price Targets
ANCR
Animalcare Group PLC
39% Upside
VENUSREM
Venus Remedies Ltd
58% Downside
WVE
WAVE Life Sciences Ltd
79% Upside
000538
Yunnan Baiyao Group Co Ltd
24% Upside
SDZ
Sandoz Group AG
9% Downside
4540
Tsumura & Co
6% Upside
3692
Hansoh Pharmaceutical Group Company Ltd
21% Upside
ARVN
Arvinas Inc
8% Upside

Revenue
Forecast

Revenue Estimate
InMed Pharmaceuticals Inc

The compound annual growth rate of InMed Pharmaceuticals Inc's revenue for the next 3 years is -35%.

N/A
Past Growth
-35%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
InMed Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
InMed Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INM's stock price target?
Not Available

INM doesn't have any price targets made by Wall Street professionals.

What is InMed Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-35%

The compound annual growth rate of InMed Pharmaceuticals Inc's revenue for the next 3 years is -35%.

Back to Top